TITLE

News

AUTHOR(S)
Kaye, Donald
PUB. DATE
January 2003
SOURCE
Clinical Infectious Diseases;1/15/2003, Vol. 36 Issue 2, pi
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Focuses on several news and developments related to medical care in the United States as of January 15, 2003. Development of early warning system against protection of biological attacks by the U.S. military; Final guidance document issues by the U.S. Food and Drug Administration (FDA) to blood centers related to blood donation; Approval given by FDA to market a test designed to diagnose pregnant women for B streptococcus.
ACCESSION #
8875005

 

Related Articles

  • NEWS. Rikein Jr., Reginald; Selby, Philip; Levine, F.A.; Revenas, B.; Appleby, John; Delamothe, Tony; Boyton, Rosemary; Warden, John // BMJ: British Medical Journal (International Edition);1/6/90, Vol. 300 Issue 6716, p5 

    Reports developments on health services around the world as of January 1990. Reformation on United States Food and Drug Administration; Revisions on the International Classification of Diseases (ICD) in Geneva; Decentralization on health care in Sweden.

  • Most Mobile Medical Apps Avoid Strict FDA Oversight.  // O&P Business News;Nov2013, Vol. 22 Issue 13, p30 

    The article reports that the U.S. Food and Drug Administration (FDA) will impose lesser regulations on mobile medical applications in the country with minimal risks.

  • Abacavir: hypersensitivity reactions.  // WHO Drug Information;2008, Vol. 22 Issue 3, p200 

    The article reports that the U.S. Food and Drug Administration (FDA) has issued an alert to healthcare professionals concerning the serious and fatal hypersensitivity reactions (HSR) caused by abacavir therapy. Accordingly, abacavir HSR is a multi-organ syndrome characterized by 2 or more...

  • Patient information leaflets come under fire. Conlan, Michael F. // Drug Topics;7/6/98, Vol. 142 Issue 13, p57 

    States that the Public Citizen's Health Research Group (HRG) requested that the United States Food and Drug Administration regulate its patient information leaflets dispensed by pharmacists. Reason for this; Comments from HRG director Sidney Wolfe, M.D.; Response from the US Pharmacopeia and...

  • FDA to boost CMI initiatives after study shows voluntary system is ineffective.  // Drug Store News;1/19/2009, Vol. 31 Issue 1, p41 

    The article reports on the plan of the U.S. Food and Drug Administration (FDA) to enhance consumer medication information (CMI). FDA stresses that the move aims to meet the needs and demands of consumers concerning the provision of quality information on the use of medicines. It reveals that the...

  • Patient-care software a device--FDA. Morrissey, John // Modern Healthcare;09/30/96, Vol. 26 Issue 40, p6 

    Reports on the plans of the United States Food and Drug Administration (FDA), to classify healthcare software as medical devices. Reason for the move by the FDA; What software used in decisions relating to patient care will be classified as; Who the plan of the FDA will affect.

  • THE WEATHERVANE. Stodd, Russell T. // Hawaii Medical Journal;Apr2008, Vol. 67 Issue 4, p114 

    This section offers news briefs on various issues including medical, sports and social. The U.S. Food and Drug Administration (FDA) rejected the plan of Merck to dispense 20 milligrams of its Mevacor drug over the counter without prescription. According to data from Pew Research Center, 36% of...

  • Largest Woodford holding GSK hit by $3bn fine. Jackson, Gary // Fundweb;7/3/2012, p13 

    The article reports that GlaxoSmithKline (GSK) will have to pay 3 billion dollars for the largest ever health care fraud of the U.S. It states that the company was pleaded guilty for criminal charges for mis-selling of drugs and withholding of data. It mentions that GSK promoted two...

  • Dialysis manufacturer agrees to correct problems. Ropp, Kevin L. // FDA Consumer;Jun94, Vol. 28 Issue 5, p30 

    States that National Medical Care, Inc., of Waltham, Massachusetts, has agreed to correct significant problems arising at five United States and two overseas manufacturing facilities to prevent having to shut down its operations. Bringing facilities into compliance with the Food and Drug...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics